FSCN1 and cancer: Increasing evidence has shown that elevated levels of fascin in many types of metastatic cells contribute to cancer cell migration and invasion during metastatic dissemination, and are correlated with clinically aggressive phenotypes, poor prognosis and overall survival 10-12.